How Long Does Semaglutide Stay in Your System?

Summary: Semaglutide has a terminal half-life of roughly 165 hours, about one week, so after five half-lives the drug is essentially cleared at around 35 days from the last dose.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: semaglutide has a half-life of about 7 days, and the drug is essentially cleared from your system 35 days after your last dose. That is the rule of five half-lives applied to the published population PK data, and it is the number every prescriber works from when planning surgery, pregnancy, or a switch to another medication ^[1][3].

Below is the pharmacology, the week-by-week washout, and the specific situations where the 35-day number actually matters.

Pharmacokinetics in plain numbers

Semaglutide's terminal half-life is ~165 hours, which rounds to 7 days ^[3]. The Novo Nordisk population PK analysis pinned the value at 165 hours across the Phase 3 type 2 diabetes program, and the FDA Ozempic label uses the same one-week figure ^[1]. Wegovy, which is the same molecule at the higher 2.4 mg weekly dose for weight management, has the same half-life because the drug itself is identical ^[2].

Three structural features are doing the heavy lifting here.

• Albumin binding above 99%. A fatty acid side chain on semaglutide latches onto serum albumin. Once bound, the drug stays in circulation instead of being filtered out by the kidneys ^[3]. The protein binding number is the single biggest reason a once-weekly injection works at all.
• Resistance to DPP-4 cleavage. Native GLP-1 is degraded within 1 to 2 minutes by dipeptidyl peptidase-4. Semaglutide has amino acid substitutions at positions 8 and 34 that block that enzyme, so the molecule sticks around for days, not seconds.
• Slow proteolytic breakdown. Semaglutide is not metabolized by CYP450 liver enzymes the way most small-molecule drugs are. It is broken down by ubiquitous proteases throughout the body and then by beta-oxidation of the fatty acid chain ^[1]. Inactive fragments leave through urine and feces. Roughly 3% of an administered dose shows up unchanged in urine.

The clearance value reported in the label is about 0.05 L/h, which is glacial compared to most injectables. That is why steady-state plasma levels take 4 to 5 weeks of weekly dosing to build, and it is why those same levels take 4 to 5 weeks to drain back to zero.

The five half-lives rule, and what 35 days actually means

Pharmacology textbooks teach that a drug is functionally eliminated after about five half-lives. The math is simple: each half-life cuts the remaining drug by 50%.

• 1 half-life (day 7): 50% remains
• 2 half-lives (day 14): 25% remains
• 3 half-lives (day 21): 12.5% remains
• 4 half-lives (day 28): 6.25% remains
• 5 half-lives (day 35): 3.1% remains

By day 35 the residual is too small to produce a clinically meaningful effect. Trace amounts can still be detected by sensitive assays for another week or two, particularly in people who were on the maximum 2.4 mg Wegovy dose for many months, but the receptor-level activity is effectively gone.

This is the same answer whether your last dose was Ozempic 0.25 mg, Wegovy 2.4 mg, or Rybelsus 14 mg. The molecule is identical and the half-life is the same. A 0.25 mg starter dose of Ozempic clears faster only because there was less to clear in the first place; the rate of clearance is unchanged.

Week-by-week: what stopping semaglutide actually looks like

The pharmacokinetics drive the experience. Plasma levels drop by half each week, and the clinical effects fade roughly in step.

Week 1 to 2: barely any change

If you were on a steady weekly dose, your blood level seven days after the last injection is the same level you walked around with all year. You are still 50% saturated at day 7 and 25% at day 14. Appetite suppression, slowed gastric emptying, and glycemic effects all stay near normal during this window. Most people who stop without telling their prescriber do not notice anything different in the first 10 days, which is why they sometimes assume they can quit without consequences.

Week 3 to 5: the washout window

Between day 21 and day 35, drug levels fall from about 12.5% to 3% of steady state. This is when the body notices.

• Appetite returns. Food noise, which is the running mental chatter about what to eat next, comes back in this window. Many people report it returning around day 17 to 21 and reaching pre-treatment levels by week 4 to 5.
• Gastric emptying speeds up. Meals empty faster, fullness arrives later, and snack hunger returns. The fullness signal that made small portions feel adequate is gone.
• Glucose rises in type 2 diabetes. Fasting glucose and A1c trend upward. If you were on semaglutide for diabetes and stopped without a bridge, your provider will want labs at the 4-week mark to catch the rebound.
• Weight regain begins. The STEP 1 extension trial documented this precisely. Participants who stopped semaglutide regained two-thirds of the weight they had lost within one year, and the regain curve started right at the washout point ^[5].

Week 5 and beyond: cleared

By day 35 the drug is essentially gone. From here forward, your physiology is whatever it would have been without semaglutide, modulated by whatever lifestyle changes you locked in during treatment. The hormone, GLP-1, that semaglutide imitates is still being produced by your own gut in normal amounts. Your body simply is not getting the steady supplemental signal anymore.

Implications for surgery: stop 7 to 14 days before

GLP-1 receptor agonists slow gastric emptying, which means food can remain in the stomach long after the standard 8-hour fast that anesthesia teams rely on. That residual food is an aspiration risk during induction. Several reports of solid gastric contents in fully fasted GLP-1 patients prompted a guideline update.

The 2024 multisociety guidance from the American Society of Anesthesiologists and gastroenterology societies recommends holding weekly GLP-1 agonists for one week before an elective procedure that requires deep sedation or general anesthesia ^[4]. For semaglutide specifically, that means skipping the dose due in the seven days before surgery. Some anesthesia groups extend the hold to 10 to 14 days for high-risk cases, since one half-life still leaves 50% of the drug on board. Always confirm the timeline with the actual anesthesia team for your procedure rather than guessing.

If you cannot hold the drug, the guidance recommends a 24-hour clear-liquid diet before the procedure or point-of-care gastric ultrasound at induction. Do not interrupt diabetes management without a replacement plan; if you stop semaglutide for surgery and have type 2 diabetes, your prescriber needs to bridge you with another agent.

Pregnancy: stop at least 2 months before conception

The Ozempic and Wegovy labels both carry the same instruction: discontinue at least 2 months before a planned pregnancy ^[1][2]. The reason is straightforward. With a 7-day half-life and a 5-week washout, you need a buffer to be confident the drug is fully cleared before conception. Two months provides about 8 half-lives, which drops residual drug below 0.5% of steady state.

Animal reproduction studies showed adverse developmental outcomes at clinically relevant exposures, and human data are limited. The FDA does not have enough safety information to recommend semaglutide during pregnancy. If you become pregnant while taking it, stop immediately and call your prescriber the same day. Diabetes that was being managed on semaglutide will need a pregnancy-safe alternative, typically insulin, started right away.

Breastfeeding data are also limited. The label advises weighing the developmental and health benefits of breastfeeding against the mother's clinical need for semaglutide and any potential adverse effects on the infant.

Dose changes follow the same clock

Every titration step you make is governed by the same 4 to 5 week steady-state rule. When you go from 0.5 mg to 1 mg weekly, plasma levels do not jump immediately; they climb over about four weeks and plateau at the new equilibrium. That is why the FDA-recommended titration schedule waits at least 4 weeks between dose increases for both Ozempic and Wegovy ^[1][2].

The same lag works in reverse if you step down. Cutting from 2 mg back to 1 mg drops your steady state to roughly half over 4 to 5 weeks. If you were planning to discontinue altogether, there is no pharmacologic reason to taper. Stopping cold from any dose results in the same 35-day washout, because the half-life does not change with dose.

If you switch from semaglutide to another GLP-1 agonist (tirzepatide, dulaglutide, or liraglutide), the standard practice is to start the new drug at its lowest titration dose on the date the next semaglutide dose would have been due, one week after the last semaglutide injection. There is overlap during the first month while semaglutide washes out and the new drug builds up. That overlap is intentional. It prevents the appetite-and-glucose rebound that would otherwise occur during the transition.

Why kidney and liver function do not change the answer much

Most drugs accumulate when the kidneys or liver are impaired. Semaglutide largely does not. The clearance pathway is enzymatic breakdown by ubiquitous proteases, not renal filtration or hepatic CYP metabolism. The FDA label notes no clinically meaningful difference in semaglutide PK across mild, moderate, or severe renal impairment, including patients on dialysis ^[1]. Hepatic impairment similarly does not require dose adjustment.

What does affect personal clearance is body composition, age, and concurrent medications that change albumin binding or gastric emptying. Even there, the population PK paper found the differences too small to require individualized dosing ^[3]. Five weeks is the right answer for nearly everyone.

Detection in drug tests

Semaglutide is not on any standard drug screening panel. Workplace urine tests, sports anti-doping panels (it is not banned by WADA at the time of writing), and routine pre-surgical labs do not look for it. Specialized LC-MS assays can detect semaglutide in plasma for several weeks after the last dose, but those are research tools, not clinical or forensic tests. If a test is specifically ordered for semaglutide, expect the drug to be measurable for 5 to 7 weeks after stopping.

Common questions about how long semaglutide lasts

How long does semaglutide stay in your system after stopping?

About 35 days for the drug itself, since the half-life is roughly 7 days and five half-lives clears most substances. Effects on appetite and glucose fade gradually across weeks 3 to 5.

How long does Ozempic stay in your system?

Same as any semaglutide product: 4 to 5 weeks. Ozempic and Wegovy contain identical molecules and have identical half-lives.

How long does Wegovy stay in your body?

Roughly 5 weeks after the last 2.4 mg injection. Higher steady-state concentrations from the larger weight-loss dose may push detection out toward 6 to 7 weeks, but functional effects are gone by week 5.

How long does 0.25 mg of Ozempic or Wegovy stay in your system?

The half-life is still 7 days regardless of dose. The starter dose clears faster only because the absolute amount is smaller; expect the drug to be functionally gone in 4 to 5 weeks.

How do you flush semaglutide out of your system?

You cannot. There is no validated way to accelerate clearance. Hydration, exercise, fasting, charcoal, and detox products do not move the timeline. The 35-day clock runs at the pace your enzymes set it.

How long for semaglutide to leave your system before surgery?

Anesthesia guidance recommends holding weekly semaglutide for at least 7 days before procedures with deep sedation or general anesthesia, and some teams extend the hold to 10 to 14 days. Confirm with your anesthesia team.

How long before pregnancy should I stop semaglutide?

At least 2 months before conception, per the FDA labels for both Ozempic and Wegovy. That gives roughly 8 half-lives of washout, which is well below any clinically relevant residual.

Will my appetite come back the day I stop?

No. With drug levels still at 50% one week after the last dose, most people feel little change for 10 to 14 days. Appetite typically returns noticeably around weeks 3 to 4 and reaches pre-treatment levels by week 5.

Does kidney disease change how long semaglutide stays in your body?

Not meaningfully. Semaglutide is broken down by proteases throughout the body and excreted as inactive fragments. The FDA label states no dose adjustment is needed for any level of renal impairment, including dialysis.

Can semaglutide be detected on a drug test?

Not on any standard panel. Only specialized lab assays can measure semaglutide, and they would only be ordered for a specific medical or research reason.

What this article does not cover

This page is the pharmacokinetic and washout timeline for semaglutide. Adjacent questions, like which side effects can persist after stopping, how weight regain progresses month by month, and how to transition from semaglutide to tirzepatide, have their own dedicated articles on this site. The numbers here, half-life of 7 days and clearance at 35 days, are the foundation that makes those decisions calculable in the first place.